Method
Yoy · gp.fundamentals.revenue
Raw value -18.79% · CORE
· Pharmaceutical Preparations
RESEARCH SNAPSHOTCUMBERLAND PHARMACEUTICALS INC's latest supported as-filed period reports revenue of $8.8M, 18.8% below the comparable as-filed period. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Yoy · gp.fundamentals.revenue
Raw value -18.79% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 0.34% · OPTIONAL
Level · gp.fundamentals.operating_margin
Raw value -35.91% · CORE
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Raw value 8.77% · OPTIONAL
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Research & development changed -47.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Inventory changed -99.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Each point keeps the date investors could first observe it and its accession.
CPIX · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001087294-26-000064SEC ↗10-QAug 7, 2026Period Jun 30, 20260001087294-26-000062SEC ↗8-KAug 4, 2026Period Aug 4, 20260001087294-26-000058SEC ↗8-KJul 13, 2026Period Jul 13, 20260001087294-26-000055SEC ↗8-KJul 1, 2026Period Jun 29, 20260001104659-26-079871SEC ↗8-KJun 25, 2026Period Jun 24, 20260001087294-26-000053SEC ↗10-QMay 8, 2026Period Mar 31, 20260001087294-26-000049SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Mar 18, 2026Filed Mar 20, 2026 | Brown Martin S JRDirector | Grant Or AwardDirect | 1,800 | $3 | $5,040 | Form 4 ↗ |
| Mar 18, 2026Filed Mar 20, 2026 | Galante Joseph CDirector | Grant Or AwardDirect | 1,800 | $3 | $5,040 | Form 4 ↗ |
| Mar 18, 2026Filed Mar 20, 2026 | Jones JamesDirector | Grant Or AwardDirect | 1,800 | $3 | $5,040 | Form 4 ↗ |
| Mar 18, 2026Filed Mar 20, 2026 | Krogulski KennethDirector | Grant Or AwardDirect | 1,800 | $3 | $5,040 | Form 4 ↗ |
| Mar 18, 2026Filed Mar 20, 2026 |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Inventory / revenue changed -2940 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Operating income changed -322.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating margin changed -2901 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Revenue changed -18.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Cash & equivalents changed -76.0% from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001087294-26-000046| Krogulski KennethDirector |
| Grant Or AwardDirect |
| 4,000 |
| $3 |
| $11,200 |
| Form 4 ↗ |
| Mar 18, 2026Filed Mar 20, 2026 | Young CarolineDirector | Grant Or AwardDirect | 1,800 | $3 | $5,040 | Form 4 ↗ |
| Mar 18, 2026Filed Mar 20, 2026 | Anthony Todd M.Vice Pres Organizational Dev | Grant Or AwardDirect | 3,000 | $3 | $8,400 | Form 4 ↗ |
| Mar 18, 2026Filed Mar 20, 2026 | Bitterman Chris T.Vice Pres Sales & Marketing | Grant Or AwardDirect | 3,000 | $3 | $8,400 | Form 4 ↗ |
| Mar 18, 2026Filed Mar 20, 2026 | Hamm John M.VP Chief Financial Officer | Grant Or AwardDirect | 3,000 | $3 | $8,400 | Form 4 ↗ |
| Mar 18, 2026Filed Mar 20, 2026 | Herman James LVP and Chief Compliance Office | Grant Or AwardDirect | 2,500 | $3 | $7,000 | Form 4 ↗ |
| Mar 18, 2026Filed Mar 20, 2026 | KAZIMI A JChairman and CEO | Grant Or AwardDirect | 100,000 | $3 | $280,000 | Form 4 ↗ |
| Mar 16, 2026Filed Mar 18, 2026 | KAZIMI A JChairman and CEO | Tax WithholdingDirect | 5,845 | $3 | $17,886 | Form 4 ↗ |
| Dec 31, 2025Filed Jan 6, 2026 | Young CarolineDirector | OtherDirect | 5 | $4 | $20 | Form 4 ↗ |
| Dec 30, 2025Filed Jan 6, 2026 | Young CarolineDirector | OtherDirect | 2 | $4 | $8 | Form 4 ↗ |
| Dec 29, 2025Filed Jan 6, 2026 | Young CarolineDirector | OtherDirect | 2 | $4 | $8 | Form 4 ↗ |
| Dec 26, 2025Filed Jan 6, 2026 | Young CarolineDirector | OtherDirect | 2 | $4 | $8 | Form 4 ↗ |
| Dec 24, 2025Filed Jan 6, 2026 | Young CarolineDirector | OtherDirect | 2 | $4 | $9 | Form 4 ↗ |
| Dec 23, 2025Filed Jan 6, 2026 | Young CarolineDirector | OtherDirect | 2 | $4 | $8 | Form 4 ↗ |
| Dec 22, 2025Filed Jan 6, 2026 | Young CarolineDirector | OtherDirect | 2 | $4 | $9 | Form 4 ↗ |
| Dec 19, 2025Filed Jan 6, 2026 | Young CarolineDirector | OtherDirect | 2 | $4 | $8 | Form 4 ↗ |